PTC Therapeutics | PTCT - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amgen USD 2.86B 16.65B 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Cytokinetics USD 20.51M 4.2M 2026-06
Daiichi Sankyo JPY 539.05B 57.81B 2026-06
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Gilead Sciences USD 645M 70M 2026-03
Incyte USD 1.39B 1.16B 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Novartis USD 4.26B 64M 2026-06
Pfizer USD 4.58B 75M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Puma Biotechnology USD 6.39M 962K 2025-09
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
TG Therapeutics USD 213.69M 64.85M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06
Xencor USD 12.65M 4.73M 2026-06